SalivaTec Co. to start metabolome analysis for early detection of cancer in saliva

SalivaTec, a startup in Yamagata prefecture, is working on a “Saliva checker” which detects markers for pancreatic and colon cancer early using metabolomics. In September 2017, the company tied up with Nippon Life Insurance Co. At present, a cohort of 1000 employees of Nippon Life will provide saliva samples for validation of SalivaTec’s approach.

Nikkei Biotech news release, January 18, 2018

SalivaTec Co. to start metabolome analysis for early detection of cancer in saliva
Scroll to top